Patent details

EP3252047 Title: CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS

Basic Information

Publication number:
EP3252047
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171687528
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS
French Title of Invention:
FORMES CRISTALLINES DE 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE UTILES POUR LE TRAITEMENT D'UNE CROISSANCE CELLULAIRE ANORMALE CHEZ DES MAMMIFERES
German Title of Invention:
ZUR BEHANDLUNG VON ABNORMEM ZELLWACHSTUM BEI SÄUGETIEREN GEEIGNETE KRISTALLINE FORMEN VON 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOL
SPC Number:

Dates

Filing date:
25/03/2008
Grant date:
11/05/2022
EP Publication Date:
06/12/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/05/2022
EP B1 Publication Date:
11/05/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/03/2023
Expiration date:
25/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/05/2022
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340, United States (US)

Inventor

1

Name:
MCLAUGHLING, Robert, William
Address:
United States (US)

2

Name:
CHEKAL, Brian, Patrick
Address:
United States (US)

3

Name:
SINGER, Robert, Alan
Address:
United States (US)

4

Name:
CAMPETA, Anthony, Michael
Address:
United States (US)

Priority

1

Priority Number:
910379 P
Priority Date:
05/04/2007
Priority Country:
United States (US)

2

Priority Number:
976546 P
Priority Date:
01/10/2007
Priority Country:
United States (US)

3

Priority Number:
31554
Priority Date:
26/02/2008
Priority Country:
United States (US)

Classification

IPC classification:
C07D 401/06; A61K 31/4439; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202219
Publication date:
11/05/2022
Description:
Grant (B1)

2

Issue number:
202223
Publication date:
08/06/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages